REWIND to fast forward: time to revisit stroke prevention in type 2 diabetes?
Lancet Diabetes Endocrinol · 2020
Last updated 2026-05-28| Journal | Lancet Diabetes Endocrinol, 2020 |
|---|---|
| Citations | 5 |
| Relative citation ratio | 0.18 |
| NIH percentile | 12 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Cardiovascular Risk Reduction |
Full record and abstract on PubMed 31924564 ↗